1019P - Evaluation of indoleamine 2,3-dioxygenase expression (IDO), transforming growth factor beta (TGF-β) and interleukin 13 (IL13) expression on clinical outcome in patients with Hodgkin’s lymphoma
| Autor: | Skrypets, T., Novosad, O., Pastushenko, Y., Skachkova, O., Gorbach, O., Khranovska, N., Kryachok, I. |
|---|---|
| Zdroj: | In Annals of Oncology September 2017 28 Supplement 5:v363-v364 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|